ABT Abbott Laboratories

Price (delayed)

$113.86

Market cap

$198.1B

P/E Ratio

35.81

Dividend/share

$2.16

EPS

$3.18

Enterprise value

$205.87B

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott ...

Highlights
Abbott Laboratories's debt has decreased by 12% YoY
Abbott Laboratories's net income has increased by 8% YoY
ABT's P/E is 7% above its last 4 quarters average of 33.6

Key stats

What are the main financial stats of ABT
Market
Shares outstanding
1.74B
Market cap
$198.1B
Enterprise value
$205.87B
Valuations
Price to book (P/B)
5.01
Price to sales (P/S)
4.87
EV/EBIT
28.93
EV/EBITDA
19.87
EV/Sales
5.06
Earnings
Revenue
$40.73B
EBIT
$7.12B
EBITDA
$10.36B
Free cash flow
$5.65B
Per share
EPS
$3.18
Free cash flow per share
$3.24
Book value per share
$22.74
Revenue per share
$23.36
TBVPS
$24.03
Balance sheet
Total assets
$73.02B
Total liabilities
$33.46B
Debt
$14.75B
Equity
$39.56B
Working capital
$9.36B
Liquidity
Debt to equity
0.37
Current ratio
1.68
Quick ratio
1.02
Net debt/EBITDA
0.75
Margins
EBITDA margin
25.4%
Gross margin
55.2%
Net margin
13.6%
Operating margin
15.9%
Efficiency
Return on assets
7.6%
Return on equity
14.3%
Return on invested capital
20.2%
Return on capital employed
12%
Return on sales
17.5%
Dividend
Dividend yield
1.9%
DPS
$2.16
Payout ratio
67.9%

ABT stock price

How has the Abbott Laboratories stock price performed over time
Intraday
0.67%
1 week
0.52%
1 month
3.98%
1 year
12.11%
YTD
3.44%
QTD
9.58%

Financial performance

How have Abbott Laboratories's revenue and profit performed over time
Revenue
$40.73B
Gross profit
$22.5B
Operating income
$6.48B
Net income
$5.56B
Gross margin
55.2%
Net margin
13.6%
Abbott Laboratories's net income has increased by 8% YoY
The operating income has grown by 6% YoY
Abbott Laboratories's net margin has increased by 6% YoY but it has decreased by 2.9% QoQ
Abbott Laboratories's operating margin has increased by 4.6% YoY

Growth

What is Abbott Laboratories's growth rate over time

Valuation

What is Abbott Laboratories stock price valuation
P/E
35.81
P/B
5.01
P/S
4.87
EV/EBIT
28.93
EV/EBITDA
19.87
EV/Sales
5.06
The EPS has grown by 8% YoY
ABT's P/E is 7% above its last 4 quarters average of 33.6
ABT's equity is up by 6% year-on-year
ABT's price to book (P/B) is 5% lower than its 5-year quarterly average of 5.3 but 4.4% higher than its last 4 quarters average of 4.8
ABT's P/S is 6% above its last 4 quarters average of 4.6

Efficiency

How efficient is Abbott Laboratories business performance
Abbott Laboratories's return on assets has increased by 9% YoY
ABT's ROE is down by 2.7% from the previous quarter but it is up by 2.1% YoY
The ROS has grown by 2.3% YoY

Dividends

What is ABT's dividend history
DPS
$2.16
Dividend yield
1.9%
Payout ratio
67.9%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Abbott Laboratories financials performed over time
The total assets is 118% more than the total liabilities
Abbott Laboratories's total liabilities has decreased by 7% YoY
ABT's quick ratio is up by 7% since the previous quarter and by 2% year-on-year
Abbott Laboratories's debt is 63% lower than its equity
Abbott Laboratories's debt to equity has decreased by 18% YoY
Abbott Laboratories's debt has decreased by 12% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.